ARLINGTON, VIRGINIA – Tomorrow, the House Committee on Oversight and Accountability will hold a full committee hearing on oversight of the U.S. Food and Drug Administration (FDA). The American Consumer Institute (ACI) urges a rigorous examination of the FDA’s conduct during the COVID health crisis, and the agency’s apparent disregard for incorporating risk exposure in its decision-making processes, particularly regarding tobacco harm reduction products, has placed American consumers in jeopardy, leaving them defenseless against additional health perils.

The ACI’s research underscores a staggering reality: such delays in access to tobacco harm reduction technologies have been costing hundreds of thousands of American lives annually. It is incumbent upon the Committee to scrutinize the FDA’s questionable approach to safeguarding public health and consumer safety with the utmost severity. This hearing is not merely a procedural check; it is an opportunity to confront the deficiencies that have undermined public trust and to demand accountability for actions that have significant ramifications for public well-being.

For media inquiries, please email [email protected] to inquire about the above content.

The American Consumer Institute is a nonprofit education and research organization. For more information about the Institute, visit www.TheAmericanConsumer.Org or follow us on X @ConsumerPal.